Cowen
OrganizationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Eric Assaraf
|
Employment |
5
|
1 |
HOUSE_OVERSIGHT_024888.jpg
This document is page 72 of a Cowen Collaborative Insights report dated February 25, 2019, stamped with a House Oversight Bates number. It details a partnership between Authentic Brands Group (ABG) and Tilray focused on CBD wellness products, mentioning brands like Muhammad Ali and Nine West. It also features a diagram regarding Devan Chemical's CBD-infused textile technology.
HOUSE_OVERSIGHT_024887.jpg
This document is page 71 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. The text focuses on the textile industry, specifically analyzing the use of hemp by brands like Patagonia and Nike, and the emerging technology of infusing fabrics with CBD or recovery minerals like Celliant (used by Under Armour). While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, the content itself contains no direct mentions of Jeffrey Epstein, criminal activity, or flight logs; it appears to be part of a larger subpoenaed document cache related to financial or corporate records.
HOUSE_OVERSIGHT_024882.jpg
This document is page 66 of a Cowen market research report dated February 25, 2019, analyzing U.S. eCommerce trends and CBD adoption. It features charts comparing Prime and Non-Prime purchasing habits on Amazon, specifically regarding personal care products and vitamins. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024882', indicating it was part of a document production to the House Oversight Committee, likely related to investigations involving financial institutions.
HOUSE_OVERSIGHT_024880.jpg
This document is page 64 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the healthcare payor and provider perspectives on CBD oils and medical marijuana, specifically discussing reimbursement challenges with CMS and commercial insurers, as well as policy shifts at Intermountain Healthcare in Utah. The document bears a 'HOUSE_OVERSIGHT_024880' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024879.jpg
This document is page 63 of a Cowen Collaborative Insights report dated February 25, 2019, authored by an analyst named Rhyee. It analyzes the market trends of CBD products in pharmacies, noting that independent pharmacies are adopting CBD sales faster than large chains like CVS or Walgreens due to high margins and demand. The report highlights that while Walgreens (WBA) does not sell CBD in the US, its UK subsidiary, Boots, does sell Dragonfly brand CBD oils, as illustrated by a website screenshot included in the report. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was produced during a congressional investigation.
HOUSE_OVERSIGHT_024875.jpg
This document is page 59 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the Cannabis/CBD market. It presents comparative financial data (Revenue, Gross Profit, and Gross Margin) for several companies including Charlotte's Web, CV Sciences, and Level Brands. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation document production.
HOUSE_OVERSIGHT_024873.jpg
This document is page 57 of a Cowen Collaborative Insights report dated February 25, 2019, detailing the strategies of major Canadian cannabis companies (Aphria, Aurora, Canopy Growth, Cronos, Emblem, and Emerald Health) regarding the hemp and CBD markets. It aggregates quotes from CEO earnings calls and press releases concerning market expansion into Europe and the US, as well as strategic partnerships. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024872.jpg
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024867.jpg
A Cowen 'Collaborative Insights' financial report page dated February 25, 2019, analyzing the U.S. market for CBD vapor and e-cigarettes. The document projects significant growth in the sector, forecasting CBD vape revenues to reach $360 million by 2020 and comparing this to JUUL's market share. The page includes three figures (95, 96, 97) illustrating sales forecasts and scenario analysis, and bears a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_024866.jpg
A page from a Cowen Collaborative Insights market research report dated February 25, 2019, analyzing the pricing segments of CBD confections and bars. It presents data on various brands like Lord Jones and baceae, categorizing them into Super Premium, Premium, Main, and Value segments based on price per milligram of CBD. The document bears a 'HOUSE_OVERSIGHT_024866' stamp, indicating it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024865.jpg
This document is page 49 of a financial research report by Cowen Collaborative Insights, dated February 25, 2019. It analyzes the market potential for CBD-infused food and confections in the U.S., projecting sales could surpass $400 million by 2020. The document contains charts and sensitivity analyses regarding market share and revenue growth. It bears the Bates stamp HOUSE_OVERSIGHT_024865, indicating it was part of a document production for the House Oversight Committee, though the specific content is strictly market research unrelated to specific individuals.
HOUSE_OVERSIGHT_024864.jpg
This document is page 48 of a Cowen Collaborative Insights financial research report dated February 25, 2019. It analyzes product offerings and packaging from CBD companies 'Lord Jones' and 'Charlotte's Web' (CWEB), specifically lotions, oils, and balms. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as evidence during a congressional investigation, likely related to financial oversight, though no direct mention of Jeffrey Epstein appears on this specific page.
HOUSE_OVERSIGHT_024862.jpg
This document is page 46 of a market research report produced by Cowen Collaborative Insights on February 25, 2019. It analyzes the pricing segments of CBD body lotions and bath bombs, listing various brands like Mary's Nutritionals and Lord Jones. While the content is purely financial market analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024862', indicating it was part of a document production for a House Oversight Committee investigation (likely related to financial records subpoenaed in the Epstein/Deutsche Bank probe), though the page itself contains no direct references to Epstein.
HOUSE_OVERSIGHT_024860.jpg
A page from a Cowen financial research report dated February 25, 2019, analyzing the U.S. Beauty industry and specifically projecting growth for CBD beauty products. It includes charts forecasting sales growth through 2020. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though the page itself contains no direct references to Jeffrey Epstein or illicit activity.
HOUSE_OVERSIGHT_024857.jpg
This document is page 41 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the beer market. It focuses on the growth of Hard Seltzer and the potential revenue opportunities for CBD-infused beer, projecting market values up to 2020. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024857) and is digitally watermarked for Michael Cella.
HOUSE_OVERSIGHT_024855.jpg
This document is page 39 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the market potential for CBD-infused bottled water in the U.S., utilizing Google Trends and Nielsen sales data to project revenue growth through 2020. The document bears the Bates stamp HOUSE_OVERSIGHT_024855 and is watermarked for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024854.jpg
This document is page 38 of a Cowen 'Collaborative Insights' financial report dated February 25, 2019, analyzing the CBD beverage market. It projects revenue growth to $900 million, with bottled water expected to comprise 65% of the market share. The document bears a 'HOUSE_OVERSIGHT_024854' Bates stamp, indicating it was part of a document production for a congressional investigation, though the content itself is strictly market research without direct reference to Epstein.
HOUSE_OVERSIGHT_024853.jpg
This document is page 37 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually compares four CBD topical products from companies Mary's Medicinals, Curaleaf, Highline, and Reliva, noting packaging and pricing strategies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a Congressional investigation.
HOUSE_OVERSIGHT_024851.jpg
This document is page 35 of a financial research report produced by Cowen on February 25, 2019, analyzing the U.S. CBD market, specifically focusing on 'Topicals.' The report projects the topical CBD market to grow to $1.5 billion by 2020. The document bears a 'HOUSE_OVERSIGHT_024851' Bates stamp, indicating it was obtained during a House Oversight Committee investigation, though the content of this specific page is purely financial market analysis and does not explicitly mention Jeffrey Epstein.
HOUSE_OVERSIGHT_024850.jpg
This document is page 34 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the packaging and pricing of CBD gummy products from four different companies: CV Sciences, Green Roads, Highline Wellness, and cbdMD. The document bears a 'HOUSE_OVERSIGHT_024850' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the content appears to be standard equity research unrelated to criminal activity.
HOUSE_OVERSIGHT_024848.jpg
This document is page 32 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the packaging and market positioning of four CBD/Hemp capsule brands: Mary's Medicinals, Charlotte's Web, Elixinol, and Lazarus Naturals. The page contains the Bates stamp HOUSE_OVERSIGHT_024848, indicating it was part of a document production to the House Oversight Committee, though the visible content focuses solely on commercial cannabis products.
HOUSE_OVERSIGHT_024847.jpg
This document is page 31 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. It analyzes the pricing segments of various CBD capsule brands and presents demographic data (gender, age, income) regarding CBD capsule usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely as part of a larger cache of financial or corporate records.
HOUSE_OVERSIGHT_024845.jpg
This document is page 29 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019, analyzing the CBD tincture market. It presents data on price segmentation among competitors (such as Lord Jones and Lazarus) and consumer demographics regarding tincture usage. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024845', indicating it was obtained during a House Oversight Committee investigation, likely as part of a larger cache of documents from a financial institution, though the content itself is strictly market research.
HOUSE_OVERSIGHT_024844.jpg
This document is page 28 of a financial research report produced by Cowen on February 25, 2019, analyzing the Nutraceuticals market. It specifically focuses on U.S. CBD sales projections following the 2018 Farm Bill, estimating $2.4 billion in revenue by 2020. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024844), suggesting it was part of a subpoena or discovery process involving Cowen.
HOUSE_OVERSIGHT_024843.jpg
This document is page 27 of a Cowen Collaborative Insights financial report dated February 25, 2019. The content is a market analysis of the CBD (Cannabidiol) industry, breaking down price per milligram across various product categories such as tinctures, gummies, and beauty products. While the content itself is strictly financial research regarding consumer staples, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024843', indicating it was part of a document production for a US House Oversight Committee investigation.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity